Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study
Table 2
Multivariate analyses showing the relationships between demographic or other factors and (a) an extremely good overall positive impact Anti-Clot Burden and Benefits Treatment Scale (ACTS = 5), (b) a feeling of much more satisfied with direct oral anticoagulant than warfarin (SWAN overall satisfactory score = 5).